Defilade Capital Management, L.P.
39 holdingsFiling period: 2026-06-30Current AUM: $792.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 39.1K | $46.9M | $53.7M | 6.77% | +18.4K | 2026-06-30 |
| 2 | PFE | Pfizer Inc | 1.77M | $42.7M | $53.1M | 6.69% | +307.6K | 2026-06-30 |
| 3 | VEEV | Veeva Sys Inc | 236.7K | $42.0M | $73.5M | 9.27% | -- | 2026-06-30 |
| 4 | BMRN | Biomarin Pharmaceutical Inc | 682.0K | $39.0M | $39.2M | 4.95% | -- | 2026-06-30 |
| 5 | PTCT | Ptc Therapeutics Inc | 433.7K | $35.4M | $28.0M | 3.53% | +57.5K | 2026-06-30 |
| 6 | BAX | Baxter Intl Inc | 1.46M | $31.1M | $34.3M | 4.33% | -- | 2026-06-30 |
| 7 | INSM | Insmed Inc | 281.8K | $30.0M | $31.4M | 3.97% | +86.9K | 2026-06-30 |
| 8 | ZBH | Zimmer Biomet Holdings Inc | 317.4K | $27.3M | $30.9M | 3.90% | -261,735 | 2026-06-30 |
| 9 | PODD | Insulet Corp | 176.9K | $26.9M | $27.0M | 3.40% | -- | 2026-06-30 |
| 10 | TMO | Thermo Fisher Scientific Inc | 51.9K | $26.0M | $36.8M | 4.65% | -- | 2026-06-30 |
| 11 | ABT | Abbott Laboratories | 285.8K | $25.9M | $29.9M | 3.77% | -- | 2026-06-30 |
| 12 | — | Ascendis Pharma A/S | 94.8K | $25.3M | $25.3M | 3.19% | -- | 2026-06-30 |
| 13 | SOLV | Solventum Corp | 316.5K | $24.4M | $26.4M | 3.34% | -- | 2026-06-30 |
| 14 | — | Medtronic PLC | 303.3K | $23.7M | $23.7M | 2.99% | -- | 2026-06-30 |
| 15 | ELAN | Elanco Animal Health Inc | 864.1K | $21.3M | $20.1M | 2.53% | -67,041 | 2026-06-30 |
| 16 | AGIO | Agios Pharmaceuticals Inc | 546.8K | $20.3M | $20.4M | 2.57% | -- | 2026-06-30 |
| 17 | NVST | Envista Holdings Corporation | 726.1K | $19.1M | $17.9M | 2.25% | -- | 2026-06-30 |
| 18 | RVMD | Revolution Medicines Inc | 82.8K | $15.5M | $15.8M | 1.99% | -233,145 | 2026-06-30 |
| 19 | ICUI | Icu Med Inc | 105.7K | $15.5M | $17.8M | 2.25% | -148,591 | 2026-06-30 |
| 20 | COGT | Cogent Biosciences Inc | 393.4K | $15.2M | $12.6M | 1.59% | +40.9K | 2026-06-30 |
| 21 | LNTH | Lantheus Hldgs Inc | 132.7K | $14.7M | $13.3M | 1.68% | -116,739 | 2026-06-30 |
| 22 | OCUL | Ocular Therapeutix Inc | 1.49M | $14.6M | $10.9M | 1.37% | +2.6K | 2026-06-30 |
| 23 | ELDN | Eledon Pharmaceuticals Inc | 3.53M | $13.9M | $10.7M | 1.35% | -38,789 | 2026-06-30 |
| 24 | TYRA | Tyra Biosciences Inc | 376.9K | $12.0M | $8.1M | 1.02% | -- | 2026-06-30 |
| 25 | OLMA | Olema Pharmaceuticals Inc | 924.8K | $11.6M | $6.8M | 0.85% | -579,778 | 2026-06-30 |
← Scroll →
Page 1 of 2